The Biomedical Translation Bridge (BTB) Program is an initiative of the Medical Research Future Fund, providing up to $1 million in matching funding to nurture the translation of new therapies, technologies and medical devices through to the proof of concept stage.
The BTB program is operated by MTPConnect in partnership with BioCurate, UniQuest, the Medical Device Partnering Program and the Bridge and BridgeTech programs.
Please join us and our partners at the Harry Perkins Institute of Medical Research to find out more about the next round of the BTB Program. BioCurate Director of Partnerships Dr Erid Hayes will be on the panel.